209 related articles for article (PubMed ID: 25303497)
1. A retrospective observational study of leucoreductive strategies to manage patients with acute myeloid leukaemia presenting with hyperleucocytosis.
Kuo KH; Callum JL; Panzarella T; Jacks LM; Brandwein J; Crump M; Curtis JE; Gupta V; Lipton JH; Minden MD; Sher GD; Schimmer AD; Schuh AC; Yee KW; Keating A; Messner HA
Br J Haematol; 2015 Feb; 168(3):384-94. PubMed ID: 25303497
[TBL] [Abstract][Full Text] [Related]
2. Hyperleucocytosis in paediatric acute myeloid leukaemia - the challenge of white blood cell counts above 200 × 10
Zeller B; Glosli H; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Hasle H; Abrahamsson J;
Br J Haematol; 2017 Aug; 178(3):448-456. PubMed ID: 28542715
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.
Daver N; Kantarjian H; Marcucci G; Pierce S; Brandt M; Dinardo C; Pemmaraju N; Garcia-Manero G; O'Brien S; Ferrajoli A; Verstovsek S; Popat U; Hosing C; Anderlini P; Borthakur G; Kadia T; Cortes J; Ravandi F
Br J Haematol; 2015 Mar; 168(5):646-53. PubMed ID: 25312977
[TBL] [Abstract][Full Text] [Related]
4. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
5. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
[TBL] [Abstract][Full Text] [Related]
6. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
[TBL] [Abstract][Full Text] [Related]
7. Leukapheresis do not improve early death rates in acute myeloid leukemia patients with hyperleukocytosis.
Malkan UY; Ozcebe OI
Transfus Apher Sci; 2017 Dec; 56(6):880-882. PubMed ID: 29153308
[TBL] [Abstract][Full Text] [Related]
8. Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.
Revesz D; Chelghoum Y; Le QH; Elhamri M; Michallet M; Thomas X
Ann Hematol; 2003 Nov; 82(11):684-90. PubMed ID: 12928754
[TBL] [Abstract][Full Text] [Related]
9. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study.
Stahl M; Shallis RM; Wei W; Montesinos P; Lengline E; Neukirchen J; Bhatt VR; Sekeres MA; Fathi AT; Konig H; Luger S; Khan I; Roboz GJ; Cluzeau T; Martínez-Cuadron D; Raffoux E; Germing U; Umakanthan JM; Mukherjee S; Brunner AM; Miller A; McMahon CM; Ritchie EK; Rodríguez-Veiga R; Itzykson R; Boluda B; Rabian F; Tormo M; Acuña-Cruz E; Rabinovich E; Yoo B; Cano I; Podoltsev NA; Bewersdorf JP; Gore S; Zeidan AM
Leukemia; 2020 Dec; 34(12):3149-3160. PubMed ID: 32132655
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for therapy-related acute myeloid leukaemia (t-AML)--a single centre experience.
Suvajdžić N; Cvetković Z; Dorđević V; Kraguljac-Kurtović N; Stanisavljević D; Bogdanović A; Djunić I; Colović N; Vidović A; Elezović I; Tomin D
Biomed Pharmacother; 2012 Jun; 66(4):285-92. PubMed ID: 22401928
[TBL] [Abstract][Full Text] [Related]
11. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
Dang H; Chen Y; Kamel-Reid S; Brandwein J; Chang H
Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
[TBL] [Abstract][Full Text] [Related]
12. Initial respiratory status in hyperleukocytic acute myeloid leukemia: prognostic significance and effect of leukapheresis.
Van de Louw A; Schneider CW; Desai RJ; Claxton DF
Leuk Lymphoma; 2016; 57(6):1319-26. PubMed ID: 26374497
[TBL] [Abstract][Full Text] [Related]
13. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
14. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate.
Porcu P; Danielson CF; Orazi A; Heerema NA; Gabig TG; McCarthy LJ
Br J Haematol; 1997 Aug; 98(2):433-6. PubMed ID: 9266944
[TBL] [Abstract][Full Text] [Related]
16. Early Complications of Hyperleukocytosis and Leukapheresis in Childhood Acute Leukemias.
Abla O; Angelini P; Di Giuseppe G; Kanani MF; Lau W; Hitzler J; Sung L; Naqvi A
J Pediatr Hematol Oncol; 2016 Mar; 38(2):111-7. PubMed ID: 26794706
[TBL] [Abstract][Full Text] [Related]
17. A hospital based retrospective study of factors influencing therapeutic leukapheresis in patients presenting with hyperleukocytic leukaemia.
Jin Y; Guo S; Cui Q; Chen S; Liu X; Wei Y; Pan Y; Tang L; Huang T; Shen H; Xu G; Zuo X; Liu S; Xiao H; Chen F; Gong F; Zhou F
Sci Rep; 2018 Jan; 8(1):294. PubMed ID: 29321527
[TBL] [Abstract][Full Text] [Related]
18. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
[TBL] [Abstract][Full Text] [Related]
19. The effect of volume replacement during therapeutic leukapheresis on white blood cell reduction in patients with extreme leukocytosis.
Kurnaz F; Sivgin S; Pala C; Yildirim R; Baldane S; Kaynar L; Solmaz M; Ozturk A; Eser B; Cetin M; Unal A
Transfusion; 2013 Nov; 53(11):2629-34. PubMed ID: 23451980
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic leukapheresis: 9-year experience in a University Hospital.
Parra Salinas IM; González Rodriguez VP; García-Erce JA
Blood Transfus; 2015 Jan; 13(1):46-52. PubMed ID: 24960648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]